Roche R&D Spending Surge Reflects In-House Innovation, M&A Prices

‘Costs Being Squeezed Everywhere’ To Fund R&D

 
• By Sten Stovall
Roche's R&D Spend Has Risen Steadily In Recent Years • Source: Alamy

More from Clinical Trials

More from R&D